DAXXIFY®

DAXXIFY®

DAXXIFY®

Tags

PHARMA

BRAnding

Social

EMAILS

DIGITAL

PRINT

Overview

DAXXIFY® is a prescription medicine for adults to temporarily improve the look of moderate to severe frown lines between the eyebrows. DAXXIFY® is the only frown line treatment powered by a peptide. It is a product in the Revance portfolio.

Daxxify® is a prescription medicine for adults to temporarily improve the look of moderate to severe frown lines between the eyebrows. Daxxify® is the only frown line treatment powered by a peptide. It is a product in the Revance portfolio.

Social

CO-OP Campaign

The objective of these Co-op Post were to allow Health Care Provider practices with the ability to take social post the we designed and attach limited practice branding. This way, practices that offer Daxxify® can deliver consistent messaging without the hassle of generating post themselves.

Post 1: Paid reel introducing and explaining the Daxxify® Difference to the consumer. Post 2: A static carousel that introduces the Fast, Last and Look messaging. Post 3: A static carousel that build a quiz viewers can swipe through.

Social

Engagement Reels

An extension of the "It's About Time" messaging geared to disrupt the neuromodulator market promising long-lasting effects. This series of posts was designed to feel ethereal and intended to get viewers to interact with it.

Print

Assorted Materials

The images to the left are an assortment of printed materials I have worked on. I have experience working on various formats such as one pagers, posters, banners, brochures, pamphlets, invites, booklets and whatever else the marketing team could cook up.

Email

Nurture Series

The “Nurture Series” was designed to continue communication with interested parties who found their way to the Daxxify® website organically or through paid media. After exploring the Daxxify® website people interested in trying the product could fill out a form and enter their information. After filling out a form these emails would be informative touch-points with the consumer

Thank you for coming

2024

Thank you for coming

2024

Thank you for coming

2024